Skip to content

Plain-English explainer

"Ozempic Burps" & Acid Reflux: Why It Happens & What Helps

Explained by Sofia Mendez, Patient Education Editor

We keep this plain-English — no jargon, every claim sourced.

If you have started Ozempic or Wegovy and noticed more burping — sometimes with an unpleasant, sulfur or "rotten-egg" smell — plus a creeping sense of heartburn or reflux, you are not imagining it and you are not alone. These symptoms have become common enough online to earn the nickname "Ozempic burps." Both Ozempic and Wegovy are semaglutide, the same active drug, so the effect is identical whichever brand you take. This guide explains, honestly, why it happens, how often it actually shows up in the data, what tends to help, and — importantly — the small number of situations where reflux or vomiting is a signal to call your prescriber rather than ride it out. This is general education, not medical advice for your specific case.

Why semaglutide makes you burp and reflux: it slows your stomach

The single mechanism behind almost all of semaglutide's gut side effects — nausea, fullness, constipation, and the burping and reflux — is that the drug slows gastric emptying. Food and stomach contents leave your stomach more slowly than they used to. That delay is not a malfunction; it is a core part of how GLP-1 receptor agonists curb appetite and portion size12. A dedicated study in adults with obesity confirmed that semaglutide 2.4 mg measurably delays how fast the stomach empties, especially early in treatment1.

When food and digestive gases sit in the stomach longer, two things follow. First, fermentation and slowed transit can produce more gas, and some of that gas is hydrogen sulfide — the compound responsible for the characteristic rotten-egg smell people describe in "Ozempic burps." Second, a fuller, slower-emptying stomach raises pressure against the valve at the top of the stomach (the lower esophageal sphincter), which makes it easier for acid and stomach contents to wash back up — the textbook setup for acid reflux, heartburn, and regurgitation. So the same property that makes the medicine work is the direct mechanical reason for the burps and the reflux. (The exact same slowed-transit mechanism drives the constipation and diarrhea we cover in Wegovy constipation & diarrhea.)

How it works
The same mechanism that curbs appetite — slowing how fast the stomach empties — is the direct cause of both sulfur burps and acid reflux. It is a predictable property of the drug, not a sign of harm.

How common is it, really?

Burping and reflux are real labeled effects, but they sit below the headline side effects in frequency. In Ozempic's and Wegovy's FDA prescribing information, the most common gastrointestinal adverse reactions are nausea, vomiting, diarrhea, constipation and abdominal pain; eructation (the medical term for burping) and gastroesophageal reflux disease (GERD) are listed among the reported adverse reactions as well34. They are real, documented, and dose-related — just less frequent than nausea, which affects a large minority of users.

Independent data line up with the label. A large analysis of the FDA's adverse-event reporting system found that eructation and reflux-type complaints are among the gastrointestinal signals reported with GLP-1 receptor agonists, alongside the more common nausea and vomiting5. A population-level cohort study in the journal Gut found that GLP-1 users — particularly on shorter-acting agents — had an increased rate of new GERD and its complications compared with matched controls, confirming reflux is a genuine class effect and not just anecdote6. And across the broader trial and safety literature, these gut effects are most frequent early and around dose increases, then tend to ease as the body adapts — the same time course as semaglutide's other GI symptoms78.

One honestly reassuring point: pooled trial data show that the medicine's benefit does not depend on having these symptoms — people lose weight whether or not they get GI side effects11. You do not have to suffer burps and reflux for the drug to be working.

What actually helps

Because burps and reflux trace back to a slow, full stomach, the most effective measures are the ones that ask less of your stomach at any one moment. These align with published clinical guidance for managing GLP-1 gastrointestinal effects8:

  • Eat smaller meals, and stop at the first sign of fullness. A slow-emptying stomach is easily overfilled; large meals are the most reliable trigger for both reflux and sulfur burps. Smaller, more frequent meals keep stomach pressure down.
  • Go lower-fat. Fatty, fried and very rich meals slow gastric emptying even further and relax the reflux valve — a double hit on a drug that already slows the stomach. Leaner, plainer meals are gentler.
  • Don't lie down after eating. Staying upright for two to three hours after a meal, and not eating right before bed, lets gravity help keep stomach contents down — standard, low-risk reflux advice that works especially well here.
  • Slow down and chew well. Eating fast and gulping air adds to both gas and fullness. Eating slowly reduces swallowed air and helps you notice fullness before you overshoot.
  • Ease up on the usual reflux aggravators — alcohol, large amounts of caffeine, carbonation, and very spicy foods. Alcohol is worth singling out because it is itself a gut irritant on a drug that already slows the stomach; we cover that interaction in alcohol on Wegovy & Ozempic.
  • Mind the titration. Symptoms cluster around dose increases, so if a step-up makes burps and reflux worse, that is expected — and prescribers can legitimately hold you at your current dose longer before going up. The slow dose ladder exists precisely to keep these effects tolerable; see semaglutide dosing & side effects for how the ramp works.

For heartburn that breaks through these measures, an over-the-counter antacid or acid reducer can help short-term — but clear it with your prescriber or pharmacist first, and don't use one continuously without medical input, because persistent reflux that needs ongoing treatment is itself worth a conversation.

When burps or reflux signal something that needs care

The vast majority of "Ozempic burps" and mild reflux are a tolerable nuisance that fades. But the same slowed-stomach mechanism, taken to an extreme, can cross into territory that needs medical attention — so it is worth knowing the line.

The most important signal is persistent vomiting or the feeling that food simply isn't moving — early, lasting fullness, bloating, and bringing up food eaten hours earlier. In a small number of people GLP-1 receptor agonists have been associated with severe delayed gastric emptying that behaves like gastroparesis, and pharmacovigilance analyses have flagged a gastroparesis signal with these drugs9. Endoscopy and clinical studies confirm that some users have retained stomach contents well beyond normal — which is also why anesthesiologists now ask about GLP-1 use before procedures, since a full stomach raises aspiration risk under sedation10. If you are scheduled for surgery, an endoscopy, or any procedure with anesthesia, tell the team you are on semaglutide.

Call your prescriber promptly for: vomiting you can't keep ahead of or that won't stop; reflux severe or persistent enough to disrupt sleep or eating; trouble swallowing, or food/pills feeling stuck; or severe, persistent abdominal pain — especially if it radiates to the back, with or without vomiting, which can be a sign of pancreatitis and is an urgent symptom, not a reflux one3. Frequent, long-standing reflux also deserves evaluation in its own right because, untreated over time, it can damage the esophagus. None of this is common — but these are the symptoms worth taking seriously rather than waiting out.

To be clear about what this is not: "Ozempic burps" are not a dangerous drug interaction and not a sign the medicine is harming you in most cases — they are a predictable consequence of a stomach that is emptying more slowly than it used to. The fix is almost always behavioral, and the symptom usually settles as you adjust.

A note on compounded semaglutide

Everything above reflects FDA-approved, standardized Ozempic and Wegovy34. Compounded semaglutide from some telehealth and med-spa sources is a different situation: dose accuracy and formulation can vary, titration may be looser, and the clean "symptoms ease during a slow ramp" expectation does not automatically transfer. If you are weighing where to get semaglutide, our best semaglutide providers guide compares options on price and oversight.

The honest bottom line

"Ozempic burps" — including the sulfur-smelling ones — and acid reflux are real, labeled side effects of semaglutide, driven by the delayed gastric emptying that also makes the drug work136. They are usually mild, cluster around dose increases, and ease with smaller lower-fat meals, staying upright after eating, slowing down, and a sensible titration8. The genuine red flags are persistent vomiting, food not moving, severe or radiating abdominal pain, or trouble swallowing — and always disclose semaglutide use before any procedure with anesthesia910. When in doubt, ask your prescriber rather than self-adjust. For the full evidence picture on how semaglutide works, its results and its safety profile, see our pillar guide, Semaglutide: How It Works, Results & Side Effects.

A few more quick ones

What causes "Ozempic burps"?

Semaglutide (Ozempic and Wegovy) slows how fast your stomach empties. Food and gas sit in the stomach longer, which produces more gas — some of it hydrogen sulfide, the source of the rotten-egg smell — and raises pressure that pushes contents and burps upward. It is a predictable consequence of the drug's mechanism, not a dangerous interaction.

Why do the burps smell like sulfur or rotten eggs?

The rotten-egg smell comes from hydrogen sulfide gas. When the stomach empties more slowly on semaglutide, food sits longer and fermentation produces more sulfur-containing gas, which is then burped up. It is unpleasant but generally harmless and tends to ease as your body adjusts.

Does Ozempic or Wegovy cause acid reflux?

It can. The slowed, fuller stomach raises pressure on the valve at the top of the stomach, making acid reflux, heartburn and regurgitation more likely. Reflux and eructation are listed in the FDA labels, and a population study found increased new GERD in GLP-1 users. It is usually mild and worst around dose increases.

How do I get rid of Ozempic burps and reflux?

Eat smaller, lower-fat meals and stop when full; stay upright for two to three hours after eating and avoid eating before bed; slow down and chew well; and ease up on alcohol, carbonation, caffeine and spicy foods. Symptoms cluster around dose increases, so a slower titration helps. Clear any antacid use with your prescriber.

When should reflux or vomiting on semaglutide worry me?

Call your prescriber for persistent vomiting, food feeling stuck or not moving, trouble swallowing, reflux that disrupts sleep or eating, or severe abdominal pain — especially if it radiates to the back (a possible pancreatitis sign). Rarely, GLP-1 drugs cause severe delayed emptying resembling gastroparesis. Always tell anesthesia teams you take semaglutide before any procedure.

Where this comes from

Every claim above traces back to one of these — real studies and official labeling.

  1. Friedrichsen M, Breitschaft A, Tadayon S, et al. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/33269530/
  2. Drucker DJ (2022). GLP-1 physiology informs the pharmacotherapy of obesity.. Mol Metab. https://pubmed.ncbi.nlm.nih.gov/34626851/
  3. Novo Nordisk Pharmaceutical Industries, LP (2026). OZEMPIC (semaglutide) injection, solution — FDA Prescribing Information (Adverse Reactions, incl. eructation and GERD).. DailyMed (NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  4. Novo Nordisk Pharmaceutical Industries, LP (2026). WEGOVY (semaglutide) injection / tablet — FDA Prescribing Information (Adverse Reactions, incl. eructation and gastroesophageal reflux disease).. DailyMed (NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  5. Liu L, Chen J, Wang L, et al. (2022). Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database.. Front Endocrinol (Lausanne). https://pubmed.ncbi.nlm.nih.gov/36568085/
  6. Liu BD, Udemba SC, Liang K, et al. (2024). Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study.. Gut. https://pubmed.ncbi.nlm.nih.gov/37739778/
  7. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
  8. Wharton S, Davies M, Dicker D, et al. (2022). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice.. Postgrad Med. https://pubmed.ncbi.nlm.nih.gov/34775881/
  9. Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023). Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.. JAMA. https://pubmed.ncbi.nlm.nih.gov/37796527/
  10. Jalleh RJ, Jones KL, Rayner CK, et al. (2024). Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.. J Clin Endocrinol Metab. https://pubmed.ncbi.nlm.nih.gov/39418085/
  11. Nadeem D, Taye M, Still M, et al. (2024). Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients.. Gastrointest Endosc. https://pubmed.ncbi.nlm.nih.gov/38692518/
  12. Ahrén B, Atkin SL, Charpentier G, et al. (2018). Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/29766634/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Keep exploring